Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Petri T. Kovanen
Dr Kovanen received his medical degree in 1970 from the University of Basle, Switzerland, and then his PhD degree from the University of Helsinki, Finland. He conducted his postdoctoral work (1976–1980) at the University of Texas, Health Science Center at Dallas, USA, Department of Medicine and Department of Molecular Genetics (heads: Nobel Laureates Joseph L. Goldstein and Michael S. Brown). After his return to Finland, he completed his residency in internal medicine at the University of Helsinki. In 1984 he was appointed as Scientific Director of Wihuri Research Institute, Helsinki, and currently serves as Director of the Institute.
His main research interests focus on the pathogenesis of atherosclerosis, both early atherogenesis with emphasis on the mechanisms of extracellular lipid accumulation, and late atherogenesis with emphasis on the generation of vulnerable plaques. Throughout the years, he has been studying the role of mast cells in atherogenesis, a rediscovered invader of the atherosclerotic arterial intima. Dr Kovanen has written numerous scientific articles, reviews, and book chapters on topics dealing with the pathophysiology of atherosclerosis, with special emphasis on mast cells.
Dr Kovanen is the Editor-in-Chief of Annals of Medicine, and serves on the Editorial Board of Arteriosclerosis, Thrombosis, and Vascular Biology. He has served as a Council Member of the Scandinavian Society for Atherosclerosis Research, and is currently a Councillor of the European Vascular Biology Organization. He is also a member of the Scientific Committee of the European Atherosclerosis Society, and President of the newly founded Finnish Atherosclerosis Society.
Jan Nilsson is Professor of Experimental Cardiovascular Research at Lund University, Sweden. He received his medical training at the Karolinska Institute, where he subsequently held positions as associate professor of cell biology and later as professor of medicine. Since 1996 he has been visiting Professor at the Department of Medicine, UCLA, USA. Jan Nilsson has been chairman of the working group for the pathogenesis of atherosclerosis in the European Society of Cardiology, board member of the Scandinavian Society for Atherosclerosis Research and dean of the medical school at Lund University. He is also a member of the editorial board of Atherosclerosis, Thrombosis and Vascular Biology and has previously been deputy general secretary of the Swedish Medical Research Council.
He has published over 200 papers in vascular cell biology and atherosclerosis research. His research has focused on the regulation of smooth muscle cell proliferation and the inflammatory response of the vascular wall to oxidized lipoprotein and mechanical injury. In recent years his main research projects have dealt with the role of immune responses against oxidized LDL antigens in atherosclerosis.